Trial NCT01984255

View at ClinicalTrials.gov 
Org. Study IDs: STU 102013-007
Secondary IDs: SCCC-05613

Last trial update was posted on 2016-12-29

MeSH Interventions

Bavituximab Ipilimumab

MeSH Conditions

Melanoma

Other Conditions


Stopping Reasons

standard of care improved combination treatment of ipilimumab plus nivolumab.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID